Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

CHARTWELL MOLECULES

  • FDA Approval
  • Nov. 25, 2024, 09:49 UTC
  • 50
  • 0 comments

FDA approve ETODOLAC

Comment Full text

OXFORD PHARMS

  • FDA Approval
  • Nov. 25, 2024, 09:49 UTC
  • 48
  • 0 comments

FDA approve ETODOLAC

Comment Full text

ABRAXEOLUS

  • FDA Approval
  • Nov. 25, 2024, 09:49 UTC
  • 45
  • 0 comments

FDA approve ETODOLAC

Comment Full text

NATCO PHARMA

  • FDA Approval
  • Nov. 25, 2024, 09:49 UTC
  • 40
  • 0 comments

FDA approve ETODOLAC

Comment Full text

ACTAVIS MID ATLANTIC

  • FDA Approval
  • Nov. 25, 2024, 09:49 UTC
  • 44
  • 0 comments

FDA approve IBUPROFEN

Comment Full text

SANDOZ

  • FDA Approval
  • Nov. 25, 2024, 09:49 UTC
  • 44
  • 0 comments

FDA approve ETODOLAC

Comment Full text

IMPAX LABS INC

  • FDA Approval
  • Nov. 25, 2024, 09:49 UTC
  • 46
  • 0 comments

FDA approve NABUMETONE

Comment Full text

VPNA

  • FDA Approval
  • Nov. 25, 2024, 09:49 UTC
  • 44
  • 0 comments

FDA approve DICLOFENAC SODIUM

Comment Full text

MYLAN

  • FDA Approval
  • Nov. 25, 2024, 09:49 UTC
  • 45
  • 0 comments

FDA approve KETOROLAC TROMETHAMINE

Comment Full text

TEVA

  • FDA Approval
  • Nov. 25, 2024, 09:49 UTC
  • 40
  • 0 comments

FDA approve KETOPROFEN

Comment Full text
  • Previous
  • 299
  • 300
  • 301
  • 302
  • 303
  • Next

Search

News categories

  • Technical Exchange News(11495)
  • Event(3324)
  • SEC News(214209)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(137228)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin